Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 8101-8150 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05787964
Immunity to Infection in Healthy Participants and Participants With Cancer
N/A
Active, not recruiting
200 participants
Started: Oct 1, 2022 · Completed: Sep 1, 2024
4 conditions
1 sponsor
1 location
NCT05554653
Influence of Leucine Enriched Amino Acids on Myofibrillar and Collagen Protein Synthesis
NA
Active, not recruiting
8 participants
Started: Oct 1, 2022 · Completed: Aug 31, 2024
1 condition
1 sponsor
1 location
NCT06460025
Compare Wound Sampling Methods Efficacy in Microbiology Culture
N/A
Active, not recruiting
131 participants
Started: Oct 1, 2022 · Completed: May 1, 2025
3 conditions
1 sponsor
1 location
NCT05509023
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
PHASE2
Active, not recruiting
102 participants
Started: Sep 30, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
24 locations
NCT05462353
Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH
PHASE2
Active, not recruiting
183 participants
Started: Sep 30, 2022 · Completed: Jun 10, 2025
2 conditions
1 sponsor
1 location
NCT04434729
Fetal Treatment of Galenic Malformations
NA
Active, not recruiting
25 participants
Started: Sep 30, 2022 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT05373719
Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder
N/A
Active, not recruiting
112 participants
Started: Sep 30, 2022 · Completed: Jan 20, 2027
1 condition
1 sponsor
23 locations
NCT05424757
Polyethylene Glycol Safety in Children
N/A
Active, not recruiting
158 participants
Started: Sep 30, 2022 · Completed: Jun 30, 2025
2 conditions
2 sponsors
1 location
NCT05383196
Onvansertib + Paclitaxel In TNBC
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Sep 30, 2022 · Completed: Feb 15, 2029
10 conditions
2 sponsors
3 locations
NCT05121337
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
NA
Active, not recruiting
150 participants
Started: Sep 30, 2022 · Completed: Sep 30, 2025
2 conditions
2 sponsors
1 location
NCT05153668
Everolimus Trial in Laryngotracheal Stenosis
EARLY_PHASE1
Active, not recruiting
20 participants
Started: Sep 30, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05407051
Family-Centered Treatment for Depression in Hispanic Youth
NA
Active, not recruiting
41 participants
Started: Sep 30, 2022 · Completed: Oct 31, 2024
3 conditions
1 sponsor
1 location
NCT05863559
Super Chef - an Online Program Promoting the Mediterranean Dietary Pattern to Lower Income Families
NA
Active, not recruiting
88 participants
Started: Sep 30, 2022 · Completed: Sep 30, 2026
2 conditions
2 sponsors
1 location
NCT05662241
A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
PHASE3
Active, not recruiting
194 participants
Started: Sep 30, 2022 · Completed: Feb 15, 2029
1 condition
2 sponsors
65 locations
NCT05283226
Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy
PHASE2
Active, not recruiting
21 participants
Started: Sep 30, 2022 · Completed: Jun 30, 2025
2 conditions
1 sponsor
12 locations
NCT05389527
Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma
PHASE2
Active, not recruiting
43 participants
Started: Sep 30, 2022 · Completed: Jul 31, 2025
1 condition
2 sponsors
4 locations
NCT05496855
Remote Care in People With Rheumatoid Arthritis
NA
Active, not recruiting
228 participants
Started: Sep 29, 2022 · Completed: Oct 14, 2028
1 condition
1 sponsor
1 location
NCT05541653
The IGNITE Study on Concentrated Investment in Black Neighborhoods
NA
Active, not recruiting
571 participants
Started: Sep 29, 2022 · Completed: Jun 30, 2026
6 conditions
1 sponsor
1 location
NCT05599581
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
NA
Active, not recruiting
1,562 participants
Started: Sep 29, 2022 · Completed: Jul 31, 2026
3 conditions
3 sponsors
2 locations
NCT06509763
ElectrocardioGraphic Imaging During Left bUndle Branch Implant to valiDate Ecg Criteria
NA
Active, not recruiting
50 participants
Started: Sep 29, 2022 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT05482971
A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET
PHASE2
Active, not recruiting
91 participants
Started: Sep 29, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
34 locations
NCT05699460
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
N/A
Active, not recruiting
150 participants
Started: Sep 29, 2022 · Completed: Nov 30, 2025
3 conditions
1 sponsor
11 locations
NCT05491616
Nivolumab During Active Surveillance After Neoadjuvant Chemoradiation for Esophageal Cancer: SANO-3 Study
PHASE2
Active, not recruiting
77 participants
Started: Sep 29, 2022 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT05304039
Phenotyping and Classifying Asthma Exacerbations
N/A
Active, not recruiting
200 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT05556733
FMT for Post-acute COVID-19 Syndrome
NA
Active, not recruiting
60 participants
Started: Sep 28, 2022 · Completed: Jun 30, 2024
2 conditions
1 sponsor
1 location
NCT05532722
ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
PHASE1/PHASE2
Active, not recruiting
21 participants
Started: Sep 28, 2022 · Completed: Sep 30, 2027
1 condition
1 sponsor
8 locations
NCT05546567
NOPARK Open Label Extension Study
NA
Active, not recruiting
400 participants
Started: Sep 28, 2022 · Completed: Jun 20, 2025
1 condition
1 sponsor
1 location
NCT05421286
The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events
N/A
Active, not recruiting
991 participants
Started: Sep 28, 2022 · Completed: Dec 31, 2025
3 conditions
3 sponsors
22 locations
NCT05456685
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
PHASE2
Active, not recruiting
125 participants
Started: Sep 28, 2022 · Completed: Nov 30, 2026
3 conditions
1 sponsor
69 locations
NCT05505994
The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin
PHASE3
Active, not recruiting
340 participants
Started: Sep 28, 2022 · Completed: Sep 30, 2024
5 conditions
1 sponsor
1 location
NCT05211180
Vida Sana y Completa Obesity and Food Insecurity Study
NA
Active, not recruiting
412 participants
Started: Sep 27, 2022 · Completed: Oct 31, 2027
1 condition
3 sponsors
1 location
NCT06239532
HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma
PHASE2
Active, not recruiting
28 participants
Started: Sep 27, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05611294
Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction
NA
Active, not recruiting
42 participants
Started: Sep 27, 2022 · Completed: Jun 1, 2025
2 conditions
2 sponsors
1 location
NCT05347095
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
PHASE3
Active, not recruiting
288 participants
Started: Sep 27, 2022 · Completed: Mar 25, 2027
2 conditions
1 sponsor
153 locations
NCT05466149
Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion
PHASE2
Active, not recruiting
100 participants
Started: Sep 27, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05082025
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations
PHASE2
Active, not recruiting
7 participants
Started: Sep 27, 2022 · Completed: Aug 29, 2025
2 conditions
2 sponsors
1 location
NCT05330247
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
NA
Active, not recruiting
100 participants
Started: Sep 27, 2022 · Completed: Jan 31, 2026
2 conditions
7 sponsors
1 location
NCT06063031
Nutritional Intervention and Rehabilitation Treatment in Patients With Post-COVID Condition
NA
Active, not recruiting
146 participants
Started: Sep 26, 2022 · Completed: Apr 30, 2025
1 condition
2 sponsors
1 location
NCT05418699
Real-life Data from Diabetic Patients on Closed-loop Pumps
N/A
Active, not recruiting
439 participants
Started: Sep 26, 2022 · Completed: Mar 31, 2025
1 condition
1 sponsor
5 locations
NCT03536052
Ablation at Virtual-hEart pRedicted Targets for VT
NA
Active, not recruiting
30 participants
Started: Sep 26, 2022 · Completed: Dec 1, 2025
2 conditions
1 sponsor
1 location
NCT05399875
AR Ruler to Improve Safety and Clinical Workflow During PICC Placement
NA
Active, not recruiting
20 participants
Started: Sep 26, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05428787
Resynchronization in Patients With HF in AF Trial Undergoing Pace & AVNA Strategy With LBBAP Compared With BiV Pacing
NA
Active, not recruiting
284 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2024
3 conditions
2 sponsors
1 location
NCT05361434
A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults
N/A
Active, not recruiting
311 participants
Started: Sep 26, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
66 locations
NCT05261906
The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exercise Study
NA
Active, not recruiting
184 participants
Started: Sep 26, 2022 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT05329961
Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old
EARLY_PHASE1
Active, not recruiting
155 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2028
1 condition
2 sponsors
1 location
NCT05591989
Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON)
NA
Active, not recruiting
80 participants
Started: Sep 26, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
10 locations
NCT05534022
Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression.
NA
Active, not recruiting
40 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05534581
SINGLE SHOT CHAMPION
PHASE4
Active, not recruiting
210 participants
Started: Sep 26, 2022 · Completed: Jan 31, 2027
1 condition
2 sponsors
2 locations
NCT06153862
Africa Ready Malaria Screening
NA
Active, not recruiting
1,640 participants
Started: Sep 23, 2022 · Completed: Sep 30, 2025
1 condition
6 sponsors
1 location
NCT05296512
Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer
PHASE2
Active, not recruiting
30 participants
Started: Sep 23, 2022 · Completed: Nov 15, 2027
2 conditions
2 sponsors
3 locations
Previous
1
More pages
160
161
162
163
164
165
166
More pages
431
Next